Strategic Science Technologies, LLC (SST) is a privately funded biotechnology company based in Cambridge, MA. They specialize in developing innovative topical drug delivery technology to formulate active pharmaceutical ingredients, providing targeted local delivery at therapeutic levels. With three programs already in clinical trials, SST is focused on becoming the first FDA approved product for the treatment of Female Sexual Arousal Disorder (FSAD). SST has recently made headlines with their collaboration with Dar Bioscience, Inc., initiating a content validity study and entering into a license and collaboration agreement for a potential therapy called Sildenafil Cream, 3.6. This product holds the potential to receive the first FDA approval for FSAD, addressing a significant unmet medical need. With their cutting-edge technology and dedication to advancing treatment options, SST is poised to make a significant impact in the field of biotechnology and women's health.Generated from the website

Goodman, Jessica

Farm Aid

Home for Little Wanderers